Bildkälla: Stockfoto

BTS: Rapidly returning to life - ABG

2021 guidance upgrade gives +6% on 2021e adj. EBITA
2022e-23e adj. EBITA rises by 3-5%
Impressive recovery, share at 22.8x 2022e EV/EBITA

BTS’ 40% FX-adjusted growth in Q3’21 (36% estimated organic) was 6% ahead of our expectations, and driven by strong growth in North America and Other markets. The European business, which showed to 1% growth y-o-y (3% estimated organic), was negatively affected by the German operation, which completed two large orders in Q2 before a slower start to Q3, according to the company. However, we expect Germany to return to normal and we find business activity in strategy implementation, consulting, and training to be strong, as companies are changing rapidly right now, so the need for BTS’ services seems high and it is benefitting from its opportunistic and clever way of handling the pandemic, i.e. keeping all of its employees and quickly going virtual and digital.

We think that the business mix of virtual and physical deliveries will normalise in the coming year, but more to a level where they are equally likely. This should, in our view, affect sales positively while weighing on EBITA margins, as deliveries now require more costs for traveling etc. We therefore estimate the 2021e adj. EBITA margin of 14.9% to decrease to 14.5% in 2022e, despite delivering 12% organic growth. The share currently trades at 22.8x 2022e EV/EBITA.
Börsvärldens nyhetsbrev
ANNONSER